Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6G9H

Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2

Experimental procedure
Experimental methodSINGLE WAVELENGTH
Source typeROTATING ANODE
Source detailsRIGAKU FR-X
Temperature [K]100
Detector technologyPIXEL
Collection date2015-02-03
DetectorDECTRIS PILATUS 300K
Wavelength(s)1.54178
Spacegroup nameP 1 21 1
Unit cell lengths48.914, 70.673, 60.884
Unit cell angles90.00, 110.31, 90.00
Refinement procedure
Resolution38.480 - 1.730
R-factor0.164
Rwork0.162
R-free0.21300
Structure solution methodFOURIER SYNTHESIS
RMSD bond length0.013
RMSD bond angle1.070
Data reduction softwareXDS
Data scaling softwareAimless
Phasing softwareBUSTER
Refinement softwareBUSTER (2.11.7)
Data quality characteristics
 OverallOuter shell
Low resolution limit [Å]45.8701.770
High resolution limit [Å]1.7301.730
Rmerge0.0260.395
Rmeas0.0260.395
Number of reflections406591259
<I/σ(I)>24.7
Completeness [%]90.750.2
Redundancy2.9
Crystallization Conditions
crystal IDmethodpHtemperaturedetails
1VAPOR DIFFUSION, SITTING DROP7.22930.3M (NH4)2SO4, 32.0%w/v MPEG 2000, 0.1M HEPES/NaOHpH=7.2, 0.02M Mercaptoethanol

223532

PDB entries from 2024-08-07

PDB statisticsPDBj update infoContact PDBjnumon